Longwood Fund II, L.P., 10% Owner at Flex Pharma, Inc. (FLKS), bought 89,680 shares at $7.00 ($628K) on 2016-03-11, disclosed to the SEC on 2016-03-15.
Open-market purchase of $628k FLKS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |